Avid Bioservices Quote - CDMOP

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

25.06

Bid

18.00

Ask

26.00

Volume

0.00 Day's Range 0.00

0.00 52 Week Range 0.00

Market Cap

1.591B

Previous Close

25.06

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

63,480,000

Dividend Yield

PE Ratio

-4.58

Earnings Per Share (EPS)

-2.22

Revenue

139.91M

Net Profit

-140.75M

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP cli... Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. The company provides a comprehensive range of process development and high-quality CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.peregrineinc.com

Headquarters

Wilmington, Delaware, USA

Founded

Avid Bioservices to Participate in Craig-Hallum Bioprocessing Conference

TUSTIN, Calif., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve...

Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024

-- Recorded First Quarter Revenue of $40.2 Million -- -- Signed $66 Million in Net New Business, Resulting in Backlog of $219 Million -- -- Maintained FY2025 Revenue Guidance of Between $160...

Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024

TUSTIN, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve...

Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024

-- Recorded Fourth Quarter Revenue of $43.0 Million – Highest in Company History -- -- Signed $30 Million in Net New Business Resulting in Backlog of $193 Million -- -- New Mammalian and Cell...

Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024

TUSTIN, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	PR
4	0	0	0	0	0	0	0	PR
12	0	0	0	0	0	0	0	PR
26	0	0	0	0	0	0	0	PR
52	0	0	0	0	0	0	0	PR
156	0	0	0	0	0	0	0	PR
260	0	0	0	0	0	0	0	PR

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DRUGBright Minds Biosciences Inc	US$ 47.37 (118.29%)	27.24M
BIVIBioVie Inc	US$ 2.3304 (108.07%)	52.3M
HEPSD Market Electronic Services and Trading	US$ 3.52 (60.00%)	43.86M
LTBRLightbridge Corporation	US$ 6.98 (56.85%)	7.72M
PEGYPineapple Energy Inc	US$ 8.19 (48.64%)	31.69M
NKGNNKGen Biotech Inc	US$ 0.3974 (-43.23%)	5.06M
ORGSOrgenesis Inc	US$ 2.1001 (-35.14%)	486.29k
BIAFbioAffinity Technologies Inc	US$ 1.40 (-34.27%)	1.45M
VEVVicinity Motor Corporation	US$ 0.0466 (-31.27%)	37.52M
CETXCemtrex Inc	US$ 0.299 (-27.07%)	20.69M
JTAIJet AI Inc	US$ 0.1008 (4.02%)	347.49M
NVDANVIDIA Corporation	US$ 138.00 (0.78%)	175.79M
SQQQProShares UltraPro Short QQQ	US$ 7.13 (-1.79%)	105.78M
TVGNTevogen Bio Holdings Inc	US$ 1.72 (24.64%)	101.27M
LCIDLucid Group Inc	US$ 2.625 (-2.42%)	80.88M